Cargando…
Efficacy and safety clinical trial with efavirenz in patients diagnosed with adult Niemann-pick type C with cognitive impairment
Niemann-Pick disease Type C (NPC) is a genetic, incurable, neurodegenerative disorder. This orphan disease is most frequently caused by mutations in the NPC1 protein, resulting in intralysossomal cholesterol accumulation. NPC1 is found in neuronal cell bodies, axon terminals and synaptosomes, sugges...
Autores principales: | Gascón-Bayarri, Jordi, Simon, Petru Cristian, Llop, Roser, Carnaval, Thiago, Ledesma, María Dolores, Rico, Imma, Sánchez-Castañeda, Cristina, Campdelacreu-Fumadó, Jaume, Calvo-Malvar, Nahum, Cos, Mònica, de Lama, Eugenia, Cortés-Romera, Montserrat, Rodríguez-Bel, Laura, Pérez-Sousa, Celia, Cerdán Sánchez, María, Muelas, Nuria, Sevillano, María Dolores, Mir, Pablo, López de Munain, Adolfo, Ferrer, Anna, Videla, Sebastián |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726274/ https://www.ncbi.nlm.nih.gov/pubmed/36482560 http://dx.doi.org/10.1097/MD.0000000000031471 |
Ejemplares similares
-
NPC1 enables cholesterol mobilization during long‐term potentiation that can be restored in Niemann–Pick disease type C by CYP46A1 activation
por: Mitroi, Daniel N, et al.
Publicado: (2019) -
Suspected adverse events following immunization against SARS-CoV2 in a university hospital in 2021: Observational study
por: Rodríguez, Dolores, et al.
Publicado: (2022) -
Niemann-Pick Disease: An Approach for Diagnosis in Adulthood
por: Patiño-Escobar, Bonell, et al.
Publicado: (2019) -
Platelet miRNA Biosignature Discriminates between Dementia with Lewy Bodies and Alzheimer’s Disease
por: Gámez-Valero, Ana, et al.
Publicado: (2021) -
Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C
por: Bremova-Ertl, Tatiana, et al.
Publicado: (2021)